1. Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. Published online April 5, 2021. doi:10.1002/ijc.33588
2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7-33. doi:10.3322/caac.21654
3. Hutten BA, Prins MH, Gent M, Ginsberg J, Tijssen JG, Büller HR. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. J Clin Oncol Off J Am Soc Clin Oncol. 2000;18(17):3078-3083. doi:10.1200/JCO.2000.18.17.3078
4. Potts JE, Iliescu CA, Lopez Mattei JC, et al. Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States. Eur Heart J. 2019;40(22):1790-1800. doi:10.1093/eurheartj/ehy769
5. Nouhravesh N, Strange JE, Tønnesen J, et al. Prognosis of acute coronary syndrome stratified by cancer type and status -A nationwide cohort study. Am Heart J. Published online November 9, 2022:S0002-8703(22)00281-2. doi:10.1016/j.ahj.2022.11.001
6. Henriksen DP, Rasmussen L, Hansen MR, Hallas J, Pottegård A. Comparison of the Five Danish Regions Regarding Demographic Characteristics, Healthcare Utilization, and Medication Use—A Descriptive Cross-Sectional Study. PLoS ONE. 2015;10(10):e0140197. doi:10.1371/journal.pone.0140197
7. Diagnostisk pakkeforløb 2022 Sundhedsstyrelsen. https://www.sst.dk/-/media/Udgivelser/2022/Pakkeforloeb/Diagnostisk-Pakkeforloeb.ashx. Accessed October 2, 2022.
8. Monitorering af kraeft aarsopgoerelse. Sundhedsdatastyrelsen. https://sundhedsdatastyrelsen.dk/-/media/sds/filer/find-tal-og-analyser/sygdomme-og-behandlinger/kraeft/kraeft_monitorering/monitorering_kraeft_aarsopgoerelse_2021.pdf. Accessed October 2, 2022.
9. Helqvist L, Erichsen R, Gammelager H, Johansen M b., Sørensen H t. Quality of ICD-10 colorectal cancer diagnosis codes in the Danish National Registry of Patients. Eur J Cancer Care (Engl). 2012;21(6):722-727. doi:10.1111/j.1365-2354.2012.01350.x
10. Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen L, Sørensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449-490. doi:10.2147/CLEP.S91125
11. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83. doi:10.1186/1471-2288-11-83
12. Vesteghem C, Brøndum RF, Falkmer UG, Pottegård A, Poulsen LØ, Bøgsted M. High Validity of the Danish National Patient Registry for Systemic Anticancer Treatment Registration from 2009 to 2019. Clin Epidemiol. 2021;13:1085-1094. doi:10.2147/CLEP.S332776
13. Kearon C, Ageno W, Cannegieter SC, et al. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost. 2016;14(7):1480-1483. doi:10.1111/jth.13336
14. Opfølgning efter tyktarmskræft. Kræftens Bekæmpelse. https://www.cancer.dk/tyktarmskraeft-coloncancer/kontrol-tyktarmskraeft/. Accessed July 14, 2022
15. Opfølgning efter endetarmskræft. Kræftens Bekæmpelse. https://www.cancer.dk/endetarmskraeft-rektumcancer/kontrol-endetarmskraeft/ Accessed July 14, 2022.
16. Pakkeforløb for lungekræft 2018 Sundhedsstyrelsen, 2022. https://www.sst.dk/-/media/Udgivelser/2018/Lungekraeft/Pakkeforl%C3%B8b-for-lungekr%C3%A6ft-2018.ashx?sc_lang=da&hash=0312B32A6CB7E1473CA0DE4D38877BA5 Accessed July 14, 2022
17. Opfølgningsforløb efter brystkræft. Kræftens Bekæmpelse. https://www.cancer.dk/brystkraeft-mammacancer/kontrol-brystkraeft/ Accessed July 14, 2022
18. DBCG aarsrapport 2021. Danish Breast Cancer Cooperative Group. https://www.sundhed.dk/content/cms/79/4679_dbcgaarsrapport2021offentliggjort30062022.pdf Accessed October 2, 2022
19. Asselain B, Barlow W, Bartlett J, et al. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol. 2018;19(1):27-39. doi:10.1016/S1470-2045(17)30777-5